Enter Xaira, with $1bn for its AI in drug discovery platform
Any new company wanting to make waves in applying artificial …
Newsletters and Deep Dive digital magazine
Any new company wanting to make waves in applying artificial …
An oral therapy that can allow children and adolescents with an …
The healthcare industry is getting hit more and more frequently by …
A new programme announced by the FDA will work towards the use of …
Following her attendance at DIA Europe 2024, pharmaphorum talks to …
BeiGene has claimed a second EU approval for PD-1 inhibitor …
Sanofi has chalked up another win in a clinical trial of its oral BTK …
Novartis has posted a healthy rise in sales and profits in the first …
BenevolentAI is embarking on another round of job losses, closing its …
In an on-site interview at Reuters Pharma Europe in Barcelona, this …
After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared …
‘Digital health’ has been heralded for some time as a new era in …
Katherine Forbes, director of innovation and enterprise at Kidney Research UK, discusses the unique, evolving role of medical research charities in facilitating collaborative partnerships a
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
The Home of Accelerating Microbial-Based Drug Development
The PM Society is a not-for-profit organisation with 40 years of Giving Back.